New research published in the European Journal of Pharmacology found that THC and CBD—especially when combined in equal parts ...

Discover how cannabinoid receptor type 1 (CB1) influences resilience to stress and its potential in treating anxiety and depression by regulating the blood-brain barrier.

Ménard and colleagues described their studies in Nature Neuroscience, in a paper titled, “ Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood-brain barrier ...

Cannabinoid receptor type 1 is a protein found throughout the body that regulates pain, mood, appetite, metabolism and memory. Both CBD and THC bind to this protein. When THC attaches to the receptor, ...

Testing a cannabinoid drug in disease models The study explored the impact of WIN55.212-2, a synthetic compound targeting cannabinoid receptors, in rodent models mimicking early stages of ...

The main difference is in the location of a bond between two of its carbon atoms. This variation means there's less attraction between delta-8 and the cannabinoid receptor found on cells in your body.

References 1. K. Van Laere, et al. Relationship of Type 1 Cannabinoid Receptor Availability in the Human Brain to Novelty-Seeking Temperament. Arch Gen Psychiatry, 2009; 66 (2): 196–204. 2. A. R.

The effects are determined by the location of the receptor and the endocannabinoid it binds to. Endocannabinoids, for example, could reduce pain by targeting CB1 receptors in the spinal nerve.